Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 16, 2026 01:38 UTC |
Bhatt NaileshDirector
|
GrantCommon Stock | 2,037 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-423229 · ownership.xml · nonDerivative · entry 1 Bhatt Nailesh · CIK 0001806525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,951 F1 · price: Represents shares of common stock the reporting person elected to receive as compensation in lieu of cash pursuant to the Issuer's 2025 Equity Incentive Plan. F1 · acquired: Represents shares of common stock the reporting person elected to receive as compensation in lieu of cash pursuant to the Issuer's 2025 Equity Incentive Plan. Read SEC document |
| September 28, 2026 Filed Oct 1, 2026 01:28 UTC | GrantCommon Stock | 82,781 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-409273 · ownership.xml · nonDerivative · entry 1 Beldner Brett Douglas · CIK 0002098931 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 536,244 F1 · shares: Represents restricted stock units scheduled to vest over a three-year period, with one-third vesting on each of September 28, 2027, September 28, 2028 and September 28, 2029. F1 · price: Represents restricted stock units scheduled to vest over a three-year period, with one-third vesting on each of September 28, 2027, September 28, 2028 and September 28, 2029. F1 · acquired: Represents restricted stock units scheduled to vest over a three-year period, with one-third vesting on each of September 28, 2027, September 28, 2028 and September 28, 2029. Read SEC document |
|
| September 28, 2026 Filed Sep 30, 2026 21:27 UTC |
Nieuwkoop JeroenChief Operating Officer
|
GrantCommon Stock | 82,781 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-409271 · ownership.xml · nonDerivative · entry 1 Nieuwkoop Jeroen · CIK 0001955369 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By SBR Limited Disclosed balance after: 504,404 F1 · shares: Represents restricted stock units scheduled to vest over a three-year period, with one-third vesting on each of September 28, 2027, September 28, 2028 and September 28, 2029. F1 · price: Represents restricted stock units scheduled to vest over a three-year period, with one-third vesting on each of September 28, 2027, September 28, 2028 and September 28, 2029. F1 · acquired: Represents restricted stock units scheduled to vest over a three-year period, with one-third vesting on each of September 28, 2027, September 28, 2028 and September 28, 2029. Read SEC document |
| September 28, 2026 Filed Sep 30, 2026 21:28 UTC |
Schamis David IraDirector · CEO
|
GrantCommon Stock | 248,344 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-409272 · ownership.xml · nonDerivative · entry 1 Schamis David Ira · CIK 0001377409 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 800,666 F1 · shares: Represents restricted stock units scheduled to vest over a three-year period, with one-third vesting on each of September 28, 2027, September 28, 2028 and September 28, 2029. F1 · price: Represents restricted stock units scheduled to vest over a three-year period, with one-third vesting on each of September 28, 2027, September 28, 2028 and September 28, 2029. F1 · acquired: Represents restricted stock units scheduled to vest over a three-year period, with one-third vesting on each of September 28, 2027, September 28, 2028 and September 28, 2029. Read SEC document |
| September 17, 2026 Filed Sep 18, 2026 22:26 UTC |
Schamis David IraDirector · CEO
|
OtherCommon Stock | 416,013 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-395776 · ownership.xml · nonDerivative · entry 1 Schamis David Ira · CIK 0001377409 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 552,322 F1 · kind: Pro rata distribution from Rorschach Capital LLC, of which the reporting person is a non-managing member. Read SEC document |
| September 17, 2026 Filed Sep 18, 2026 22:26 UTC |
Diamond Robert E. Jr.Director
|
OtherCommon Stock | 832,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-395777 · ownership.xml · nonDerivative · entry 1 Diamond Robert E. Jr. · CIK 0001477048 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,510,339 F1 · kind: Pro rata distribution from Rorschach Capital LLC, of which the reporting person is a non-managing member. Read SEC document |
| September 17, 2026 Filed Sep 18, 2026 22:25 UTC |
TUDER JEFFREYDirector
|
OtherCommon Stock | 231,692 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-395775 · ownership.xml · nonDerivative · entry 1 TUDER JEFFREY · CIK 0001671976 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 272,481 F1 · kind: Pro rata distribution from Rorschach Capital LLC, of which the reporting person is a non-managing member. Read SEC document |
| August 31, 2026 Filed Sep 2, 2026 20:36 UTC |
TUDER JEFFREYDirector
|
Otherwarrant (right to buy) · Derivative | 272,578 | $0.00 Strike: $18.75 | $0.00 |
DisclosureSEC source: 0001193125-26-380314 · ownership.xml · derivative · entry 3 TUDER JEFFREY · CIK 0001671976 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 272,578 Underlying: Common Stock · 272,578 shares Expires 2030-12-02 F1 · kind: Pro rata distribution from Rorschach Capital LLC, of which the reporting person is a non-managing member. Read SEC document |
| August 31, 2026 Filed Sep 2, 2026 20:36 UTC |
TUDER JEFFREYDirector
|
Otherwarrant (right to buy) · Derivative | 272,578 | $0.00 Strike: $12.50 | $0.00 |
DisclosureSEC source: 0001193125-26-380314 · ownership.xml · derivative · entry 2 TUDER JEFFREY · CIK 0001671976 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 272,578 Underlying: Common Stock · 272,578 shares Expires 2030-12-02 F1 · kind: Pro rata distribution from Rorschach Capital LLC, of which the reporting person is a non-managing member. Read SEC document |
| August 31, 2026 Filed Sep 2, 2026 20:36 UTC |
TUDER JEFFREYDirector
|
Otherwarrant (right to buy) · Derivative | 272,578 | $0.00 Strike: $9.38 | $0.00 |
DisclosureSEC source: 0001193125-26-380314 · ownership.xml · derivative · entry 1 TUDER JEFFREY · CIK 0001671976 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 272,578 Underlying: Common Stock · 272,578 shares Expires 2030-12-02 F1 · kind: Pro rata distribution from Rorschach Capital LLC, of which the reporting person is a non-managing member. Read SEC document |
| August 31, 2026 Filed Sep 2, 2026 20:35 UTC |
Diamond Robert E. Jr.Director
|
Otherwarrant (right to buy) · Derivative | 1,253,860 | $0.00 Strike: $18.75 | $0.00 |
DisclosureSEC source: 0001193125-26-380311 · ownership.xml · derivative · entry 3 Diamond Robert E. Jr. · CIK 0001477048 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,253,860 Underlying: Common Stock · 1,253,860 shares Expires 2030-12-02 F1 · kind: Pro rata distribution from Rorschach Capital LLC, of which the reporting person is a non-managing member. Read SEC document |
| August 31, 2026 Filed Sep 2, 2026 20:35 UTC |
Diamond Robert E. Jr.Director
|
Otherwarrant (right to buy) · Derivative | 1,253,860 | $0.00 Strike: $12.50 | $0.00 |
DisclosureSEC source: 0001193125-26-380311 · ownership.xml · derivative · entry 2 Diamond Robert E. Jr. · CIK 0001477048 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,253,860 Underlying: Common Stock · 1,253,860 shares Expires 2030-12-02 F1 · kind: Pro rata distribution from Rorschach Capital LLC, of which the reporting person is a non-managing member. Read SEC document |
| August 31, 2026 Filed Sep 2, 2026 20:35 UTC |
Diamond Robert E. Jr.Director
|
Otherwarrant (right to buy) · Derivative | 1,253,860 | $0.00 Strike: $9.38 | $0.00 |
DisclosureSEC source: 0001193125-26-380311 · ownership.xml · derivative · entry 1 Diamond Robert E. Jr. · CIK 0001477048 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,253,860 Underlying: Common Stock · 1,253,860 shares Expires 2030-12-02 F1 · kind: Pro rata distribution from Rorschach Capital LLC, of which the reporting person is a non-managing member. Read SEC document |
| August 31, 2026 Filed Sep 2, 2026 20:35 UTC |
Schamis David IraDirector · CEO
|
Otherwarrant (right to buy) · Derivative | 537,585 | $0.00 Strike: $18.75 | $0.00 |
DisclosureSEC source: 0001193125-26-380309 · ownership.xml · derivative · entry 3 Schamis David Ira · CIK 0001377409 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 537,585 Underlying: Common Stock · 537,585 shares Expires 2030-12-02 F1 · kind: Pro rata distribution from Rorschach Capital LLC, of which the reporting person is a non-managing member. Read SEC document |
| August 31, 2026 Filed Sep 2, 2026 20:35 UTC |
Schamis David IraDirector · CEO
|
Otherwarrant (right to buy) · Derivative | 537,585 | $0.00 Strike: $12.50 | $0.00 |
DisclosureSEC source: 0001193125-26-380309 · ownership.xml · derivative · entry 2 Schamis David Ira · CIK 0001377409 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 537,585 Underlying: Common Stock · 537,585 shares Expires 2030-12-02 F1 · kind: Pro rata distribution from Rorschach Capital LLC, of which the reporting person is a non-managing member. Read SEC document |
| August 31, 2026 Filed Sep 2, 2026 20:35 UTC |
Schamis David IraDirector · CEO
|
Otherwarrant (right to buy) · Derivative | 537,585 | $0.00 Strike: $9.38 | $0.00 |
DisclosureSEC source: 0001193125-26-380309 · ownership.xml · derivative · entry 1 Schamis David Ira · CIK 0001377409 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 537,585 Underlying: Common Stock · 537,585 shares Expires 2030-12-02 F1 · kind: Pro rata distribution from Rorschach Capital LLC, of which the reporting person is a non-managing member. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 20:51 UTC |
Bhatt NaileshDirector
|
GrantCommon Stock | 1,588 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-296312 · ownership.xml · nonDerivative · entry 1 Bhatt Nailesh · CIK 0001806525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,914 F1 · price: Represents shares of common stock the reporting person elected to receive as compensation in lieu of cash pursuant to the Issuer's 2025 Equity Incentive Plan. F1 · acquired: Represents shares of common stock the reporting person elected to receive as compensation in lieu of cash pursuant to the Issuer's 2025 Equity Incentive Plan. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 20:52 UTC |
LEIBOWITZ LAWRENCE EDirector
|
GrantCommon Stock | 2,117 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-296316 · ownership.xml · nonDerivative · entry 1 LEIBOWITZ LAWRENCE E · CIK 0001276505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,980 F1 · price: Represents shares of common stock the reporting person elected to receive as compensation in lieu of cash pursuant to the Issuer's 2025 Equity Incentive Plan. F1 · acquired: Represents shares of common stock the reporting person elected to receive as compensation in lieu of cash pursuant to the Issuer's 2025 Equity Incentive Plan. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 20:51 UTC |
KING THOMAS C.Director
|
GrantCommon Stock | 4,764 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-296313 · ownership.xml · nonDerivative · entry 1 KING THOMAS C. · CIK 0001774975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,800 F1 · price: Represents shares of common stock the reporting person elected to receive as compensation in lieu of cash pursuant to the Issuer's 2025 Equity Incentive Plan. F1 · acquired: Represents shares of common stock the reporting person elected to receive as compensation in lieu of cash pursuant to the Issuer's 2025 Equity Incentive Plan. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 20:51 UTC |
Rosengren Eric SDirector
|
GrantCommon Stock | 4,764 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-296314 · ownership.xml · nonDerivative · entry 1 Rosengren Eric S · CIK 0001973576 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,800 F1 · price: Represents shares of common stock the reporting person elected to receive as compensation in lieu of cash pursuant to the Issuer's 2025 Equity Incentive Plan. F1 · acquired: Represents shares of common stock the reporting person elected to receive as compensation in lieu of cash pursuant to the Issuer's 2025 Equity Incentive Plan. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 21:06 UTC |
Nieuwkoop JeroenChief Operating Officer
|
GrantCommon Stock | 421,623 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-283015 · ownership.xml · nonDerivative · entry 1 Nieuwkoop Jeroen · CIK 0001955369 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By SBR Limited Disclosed balance after: 421,623 F1 · price: Represents restricted stock units ("RSUs") received on June 23, 2026 by SBR Limited, a Hong Kong company controlled by the reporting person, in connection with the entry of an executive placement agreement by and between the registrant and SBR Limited, vesting as follows: (a) as to 271,923 RSUs, ratably on an annual basis over 3 years commencing on December 2, 2026, and (b) as to 149,700 units, ratably on an annual basis over 3 years commencing on May 5, 2027. F1 · acquired: Represents restricted stock units ("RSUs") received on June 23, 2026 by SBR Limited, a Hong Kong company controlled by the reporting person, in connection with the entry of an executive placement agreement by and between the registrant and SBR Limited, vesting as follows: (a) as to 271,923 RSUs, ratably on an annual basis over 3 years commencing on December 2, 2026, and (b) as to 149,700 units, ratably on an annual basis over 3 years commencing on May 5, 2027. Read SEC document |
| May 05, 2026 Filed May 7, 2026 20:15 UTC | GrantCommon Stock | 421,623 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-211997 · ownership.xml · nonDerivative · entry 1 Beldner Brett Douglas · CIK 0002098931 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 453,463 F1 · shares: 1. Represents restricted stock units ("RSUs") the reporting person received on May 5, 2026 in connection with the entry of an employment agreement by and between the registrant and the reporting person, vesting as follows: (x) as to 271,923 RSUs, ratably on an annual basis over 3 years commencing on December 2, 2026, (y) as to 149,700 RSUs, ratably on an annual basis over 3 years commencing on May 5, 2027. F1 · price: 1. Represents restricted stock units ("RSUs") the reporting person received on May 5, 2026 in connection with the entry of an employment agreement by and between the registrant and the reporting person, vesting as follows: (x) as to 271,923 RSUs, ratably on an annual basis over 3 years commencing on December 2, 2026, (y) as to 149,700 RSUs, ratably on an annual basis over 3 years commencing on May 5, 2027. F1 · acquired: 1. Represents restricted stock units ("RSUs") the reporting person received on May 5, 2026 in connection with the entry of an employment agreement by and between the registrant and the reporting person, vesting as follows: (x) as to 271,923 RSUs, ratably on an annual basis over 3 years commencing on December 2, 2026, (y) as to 149,700 RSUs, ratably on an annual basis over 3 years commencing on May 5, 2027. Read SEC document |
|
| April 01, 2026 Filed Apr 2, 2026 18:54 UTC |
Bhatt NaileshDirector
|
GrantCommon Stock | 2,455 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-139800 · ownership.xml · nonDerivative · entry 1 Bhatt Nailesh · CIK 0001806525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,326 F1 · price: Represents restricted shares of common stock the reporting person elected to receive as compensation in lieu of cash pursuant to the Issuer's 2025 Equity Incentive Plan. F1 · acquired: Represents restricted shares of common stock the reporting person elected to receive as compensation in lieu of cash pursuant to the Issuer's 2025 Equity Incentive Plan. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 18:53 UTC |
LEIBOWITZ LAWRENCE EDirector
|
GrantCommon Stock | 3,274 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-139796 · ownership.xml · nonDerivative · entry 1 LEIBOWITZ LAWRENCE E · CIK 0001276505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,863 F1 · price: Represents restricted shares of common stock the reporting person elected to receive as compensation in lieu of cash pursuant to the Issuer's 2025 Equity Incentive Plan. F1 · acquired: Represents restricted shares of common stock the reporting person elected to receive as compensation in lieu of cash pursuant to the Issuer's 2025 Equity Incentive Plan. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 18:54 UTC |
KING THOMAS C.Director
|
GrantCommon Stock | 7,367 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-139798 · ownership.xml · nonDerivative · entry 1 KING THOMAS C. · CIK 0001774975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,036 F1 · price: Represents restricted shares of common stock the reporting person elected to receive as compensation in lieu of cash pursuant to the Issuer's 2025 Equity Incentive Plan. F1 · acquired: Represents restricted shares of common stock the reporting person elected to receive as compensation in lieu of cash pursuant to the Issuer's 2025 Equity Incentive Plan. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 18:54 UTC |
Rosengren Eric SDirector
|
GrantCommon Stock | 7,367 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-139799 · ownership.xml · nonDerivative · entry 1 Rosengren Eric S · CIK 0001973576 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,036 F1 · price: Represents restricted shares of common stock the reporting person elected to receive as compensation in lieu of cash pursuant to the Issuer's 2025 Equity Incentive Plan. F1 · acquired: Represents restricted shares of common stock the reporting person elected to receive as compensation in lieu of cash pursuant to the Issuer's 2025 Equity Incentive Plan. Read SEC document |
| February 09, 2026 Filed Feb 12, 2026 00:34 UTC |
Bhatt NaileshDirector
|
GrantCommon Stock | 40,789 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-047185 · ownership.xml · nonDerivative · entry 1 Bhatt Nailesh · CIK 0001806525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,871 F1 · price: Represents restricted stock units scheduled to vest over a three-year period, with one-third vesting on each of December 2, 2026, December 2, 2027 and December 2, 2028. F1 · acquired: Represents restricted stock units scheduled to vest over a three-year period, with one-third vesting on each of December 2, 2026, December 2, 2027 and December 2, 2028. Read SEC document |
| February 09, 2026 Filed Feb 12, 2026 00:36 UTC |
TUDER JEFFREYDirector
|
GrantCommon Stock | 40,789 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-047188 · ownership.xml · nonDerivative · entry 1 TUDER JEFFREY · CIK 0001671976 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,789 F1 · acquired: Represents restricted stock units scheduled to vest over a three-year period, with one-third vesting on each of December 2, 2026, December 2, 2027 and December 2, 2028. Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 19:35 UTC |
Diamond Robert E. Jr.Director
|
GrantCommon Stock | 40,789 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-047186 · ownership.xml · nonDerivative · entry 1 Diamond Robert E. Jr. · CIK 0001477048 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 677,589 F1 · price: Represents restricted stock units scheduled to vest over a three-year period, with one-third vesting on each of December 2, 2026, December 2, 2027 and December 2, 2028. F1 · acquired: Represents restricted stock units scheduled to vest over a three-year period, with one-third vesting on each of December 2, 2026, December 2, 2027 and December 2, 2028. Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 19:36 UTC |
Schamis David IraDirector · CEO
|
GrantCommon Stock | 40,789 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-047189 · ownership.xml · nonDerivative · entry 1 Schamis David Ira · CIK 0001377409 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136,309 F1 · acquired: Represents restricted stock units scheduled to vest over a three-year period, with one-third vesting on each of December 2, 2026, December 2, 2027 and December 2, 2028. Read SEC document |
| February 09, 2026 Filed Feb 12, 2026 00:33 UTC |
LEIBOWITZ LAWRENCE EDirector
|
GrantCommon Stock | 40,789 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-047179 · ownership.xml · nonDerivative · entry 1 LEIBOWITZ LAWRENCE E · CIK 0001276505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,589 F1 · price: Represents restricted stock units scheduled to vest over a three-year period, with one-third vesting on each of December 2, 2026, December 2, 2027 and December 2, 2028. F1 · acquired: Represents restricted stock units scheduled to vest over a three-year period, with one-third vesting on each of December 2, 2026, December 2, 2027 and December 2, 2028. Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 19:35 UTC |
Dyrness Albert D.Director
|
GrantCommon Stock | 40,789 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-047187 · ownership.xml · nonDerivative · entry 1 Dyrness Albert D. · CIK 0001664801 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,671 F1 · price: Represents restricted stock units scheduled to vest over a three-year period, with one-third vesting on each of December 2, 2026, December 2, 2027 and December 2, 2028. F1 · acquired: Represents restricted stock units scheduled to vest over a three-year period, with one-third vesting on each of December 2, 2026, December 2, 2027 and December 2, 2028. Read SEC document |
| February 09, 2026 Filed Feb 12, 2026 00:33 UTC |
KING THOMAS C.Director
|
GrantCommon Stock | 40,789 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-047181 · ownership.xml · nonDerivative · entry 1 KING THOMAS C. · CIK 0001774975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,669 F1 · price: Represents restricted stock units scheduled to vest over a three-year period, with one-third vesting on each of December 2, 2026, December 2, 2027 and December 2, 2028. F1 · acquired: Represents restricted stock units scheduled to vest over a three-year period, with one-third vesting on each of December 2, 2026, December 2, 2027 and December 2, 2028. Read SEC document |
| February 09, 2026 Filed Feb 12, 2026 00:34 UTC |
Rosengren Eric SDirector
|
GrantCommon Stock | 40,789 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-047182 · ownership.xml · nonDerivative · entry 1 Rosengren Eric S · CIK 0001973576 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,669 F1 · price: Represents restricted stock units scheduled to vest over a three-year period, with one-third vesting on each of December 2, 2026, December 2, 2027 and December 2, 2028. F1 · acquired: Represents restricted stock units scheduled to vest over a three-year period, with one-third vesting on each of December 2, 2026, December 2, 2027 and December 2, 2028. Read SEC document |
| December 04, 2025 Filed Dec 12, 2025 12:06 UTC |
Diamond Robert E. Jr.Director
|
OtherCommon Stock | 636,800 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-317229 · ownership.xml · nonDerivative · entry 1 Diamond Robert E. Jr. · CIK 0001477048 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 636,800 F1 · price: On December 2, 2025, Hyperliquid Strategies Inc (the "Company") completed its previously announced business combination (the "Closing"), pursuant to the Business Combination Agreement, dated as of July 11, 2025 (as amended on September 22, 2025, the "BCA"), by and among the Company, Sonnet BioTherapeutics Holdings, Inc. ("Sonnet"), Rorschach I LLC, TBS Merger Sub Inc. and Rorschach Merger Sub, LLC . In connection with the Closing, Rorschach Capital LLC received an aggregate of 6,580,800 shares of common stock, par value $0.01 per share, of the Company (the "Common Stock"). On December 4, 2025, Rorschach Capital LLC distributed 636,800 shares of Common Stock to Mr. Diamond, a member of Rorschach Capital LLC. Read SEC document |
| December 04, 2025 Filed Dec 12, 2025 11:54 UTC |
Schamis David IraDirector · Chief Executive Officer
|
OtherCommon Stock | 95,520 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-317198 · ownership.xml · nonDerivative · entry 1 Schamis David Ira · CIK 0001377409 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,520 F1 · price: On December 2, 2025, Hyperliquid Strategies Inc (the "Company") completed its previously announced business combination (the "Closing"), pursuant to the Business Combination Agreement, dated as of July 11, 2025 (as amended on September 22, 2025, the "BCA"), by and among the Company, Sonnet BioTherapeutics Holdings, Inc. ("Sonnet"), Rorschach I LLC, TBS Merger Sub Inc. and Rorschach Merger Sub, LLC . In connection with the Closing, Rorschach Capital LLC received an aggregate of 6,580,800 shares of common stock, par value $0.01 per share, of the Company (the "Common Stock"). On December 4, 2025, Rorschach Capital LLC distributed 95,520 shares of Common Stock to Mr. Schamis, a member of Rorschach Capital LLC. Read SEC document |
| December 04, 2025 Filed Dec 12, 2025 16:55 UTC |
LEIBOWITZ LAWRENCE EDirector
|
OtherCommon Stock | 39,800 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-317202 · ownership.xml · nonDerivative · entry 1 LEIBOWITZ LAWRENCE E · CIK 0001276505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,800 F1 · price: On December 2, 2025, Hyperliquid Strategies Inc (the "Company") completed its previously announced business combination (the "Closing"), pursuant to the Business Combination Agreement, dated as of July 11, 2025 (as amended on September 22, 2025, the "BCA"), by and among the Company, Sonnet BioTherapeutics Holdings, Inc. ("Sonnet"), Rorschach I LLC, TBS Merger Sub Inc. and Rorschach Merger Sub, LLC . In connection with the Closing, Rorschach Capital LLC received an aggregate of 6,580,800 shares of common stock, par value $0.01 per share, of the Company (the "Common Stock"). On December 4, 2025, Rorschach Capital LLC distributed 39,800 shares of Common Stock to Mr. Leibowitz, a member of Rorschach Capital LLC. Read SEC document |
| December 04, 2025 Filed Dec 12, 2025 16:58 UTC |
KING THOMAS C.Director
|
OtherCommon Stock | 23,880 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-317213 · ownership.xml · nonDerivative · entry 1 KING THOMAS C. · CIK 0001774975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,880 F1 · price: On December 2, 2025, Hyperliquid Strategies Inc (the "Company") completed its previously announced business combination (the "Closing"), pursuant to the Business Combination Agreement, dated as of July 11, 2025 (as amended on September 22, 2025, the "BCA"), by and among the Company, Sonnet BioTherapeutics Holdings, Inc. ("Sonnet"), Rorschach I LLC, TBS Merger Sub Inc. and Rorschach Merger Sub, LLC . In connection with the Closing, Rorschach Capital LLC received an aggregate of 6,580,800 shares of common stock, par value $0.01 per share, of the Company (the "Common Stock"). On December 4, 2025, Rorschach Capital LLC distributed 23,880 shares of Common Stock to Mr. King, a member of Rorschach Capital LLC. Read SEC document |
| December 04, 2025 Filed Dec 12, 2025 17:03 UTC |
Rosengren Eric SDirector
|
OtherCommon Stock | 23,880 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-317227 · ownership.xml · nonDerivative · entry 1 Rosengren Eric S · CIK 0001973576 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,880 F1 · price: On December 2, 2025, Hyperliquid Strategies Inc (the "Company") completed its previously announced business combination (the "Closing"), pursuant to the Business Combination Agreement, dated as of July 11, 2025 (as amended on September 22, 2025, the "BCA"), by and among the Company, Sonnet BioTherapeutics Holdings, Inc. ("Sonnet"), Rorschach I LLC, TBS Merger Sub Inc. and Rorschach Merger Sub, LLC . In connection with the Closing, Rorschach Capital LLC received an aggregate of 6,580,800 shares of common stock, par value $0.01 per share, of the Company (the "Common Stock"). On December 4, 2025, Rorschach Capital LLC distributed 23,880 shares of Common Stock to Mr. Rosengren, a member of Rorschach Capital LLC. Read SEC document |
| December 04, 2025 Filed Dec 12, 2025 16:51 UTC |
Beldner Brett DouglasChief Financial Officer
|
OtherCommon Stock | 31,840 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-317190 · ownership.xml · nonDerivative · entry 1 Beldner Brett Douglas · CIK 0002098931 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,840 F1 · price: On December 2, 2025, Hyperliquid Strategies Inc (the "Company") completed its previously announced business combination (the "Closing"), pursuant to the Business Combination Agreement, dated as of July 11, 2025 (as amended on September 22, 2025, the "BCA"), by and among the Company, Sonnet BioTherapeutics Holdings, Inc. ("Sonnet"), Rorschach I LLC, TBS Merger Sub Inc. and Rorschach Merger Sub, LLC . In connection with the Closing, Rorschach Capital LLC received an aggregate of 6,580,800 shares of common stock, par value $0.01 per share, of the Company (the "Common Stock"). On December 4, 2025, Rorschach Capital LLC distributed 31,840 shares of Common Stock to Mr. Beldner, a member of Rorschach Capital LLC. Read SEC document |
| December 04, 2025 Filed Jan 7, 2026 21:05 UTC |
Nieuwkoop JeroenChief Operating Officer
|
OtherCommon Stock | 31,840 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-006289 · ownership.xml · nonDerivative · entry 1 Nieuwkoop Jeroen · CIK 0001955369 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,840 F1 · price: On December 2, 2025, Hyperliquid Strategies Inc (the "Company") completed its previously announced business combination (the "Closing"), pursuant to the Business Combination Agreement, dated as of July 11, 2025 (as amended on September 22, 2025, the "BCA"), by and among the Company, Sonnet BioTherapeutics Holdings, Inc. ("Sonnet"), Rorschach I LLC, TBS Merger Sub Inc. and Rorschach Merger Sub, LLC . In connection with the Closing, Rorschach Capital LLC received an aggregate of 6,580,800 shares of common stock, par value $0.01 per share, of the Company (the "Common Stock"). On December 4, 2025, Rorschach Capital LLC distributed 31,840 shares of Common Stock to Mr. Nieuwkoop, a member of Rorschach Capital LLC. Read SEC document |
| December 02, 2025 Filed Dec 12, 2025 16:55 UTC |
Bhatt NaileshDirector
|
OtherCommon Stock | 2,082 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-317206 · ownership.xml · nonDerivative · entry 1 Bhatt Nailesh · CIK 0001806525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,082 F1 · price: On December 2, 2025, Hyperliquid Strategies Inc (the "Company") completed its previously announced business combination (the "Closing"), pursuant to the Business Combination Agreement, dated as of July 11, 2025 (as amended on September 22, 2025, the "BCA"), by and among the Company, Sonnet BioTherapeutics Holdings, Inc. ("Sonnet"), Rorschach I LLC, TBS Merger Sub Inc. and Rorschach Merger Sub, LLC . In connection with the Closing, Ms. Nailesh Bhatt received 2,082 shares of common stock, par value $0.01 per share, of the Company, in exchange of certain securities of Sonnet Ms. Bhatt held prior to the Closing. Read SEC document |
| December 02, 2025 Filed Dec 12, 2025 16:52 UTC |
TUDER JEFFREYDirector
|
OtherWarrants · Derivative | 16,000 | Not disclosed Strike: $6.25 | Not disclosed |
DisclosureSEC source: 0001193125-25-317191 · ownership.xml · derivative · entry 2 TUDER JEFFREY · CIK 0001671976 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2025-07-14 F3 · price: In connection with the Closing, Tremson received warrants to purchase an aggregate of 16,000 shares of Common Stock, at an initial exercise price of $6.25 per share, in exchange of certain warrants of Sonnet Tremson held prior to the Closing. F2 · ownership.nature: The securities are held directly by Tremson and indirectly by Jeffrey Tuder, managing member of Tremson. Mr. Tuder disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| December 02, 2025 Filed Dec 12, 2025 16:52 UTC |
TUDER JEFFREYDirector
|
OtherCommon Stock | 8,188 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-317191 · ownership.xml · nonDerivative · entry 1 TUDER JEFFREY · CIK 0001671976 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 8,188 F1 · price: On December 2, 2025, Hyperliquid Strategies Inc (the "Company") completed its previously announced business combination (the "Closing"), pursuant to the Business Combination Agreement, dated as of July 11, 2025 (as amended on September 22, 2025, the "BCA"), by and among the Company, Sonnet BioTherapeutics Holdings, Inc. ("Sonnet"), Rorschach I LLC, TBS Merger Sub Inc. and Rorschach Merger Sub, LLC . In connection with the Closing, Tremson Capital Management, LLC ("Tremson") received 8,188 shares of common stock, par value $0.01 per share, of the Company (the "Common Stock"), in exchange of certain securities of Sonnet Tremson held prior to the Closing. F2 · ownership.nature: The securities are held directly by Tremson and indirectly by Jeffrey Tuder, managing member of Tremson. Mr. Tuder disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| December 02, 2025 Filed Dec 23, 2025 13:03 UTC |
Dyrness Albert D.Director
|
OtherCommon Stock | 882 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-330461 · ownership.xml · nonDerivative · entry 1 Dyrness Albert D. · CIK 0001664801 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 882 F1 · price: On December 2, 2025, Hyperliquid Strategies Inc (the "Company") completed its previously announced business combination (the "Closing"), pursuant to the Business Combination Agreement, dated as of July 11, 2025 (as amended on September 22, 2025, the "BCA"), by and among the Company, Sonnet BioTherapeutics Holdings, Inc. ("Sonnet"), Rorschach I LLC, TBS Merger Sub Inc. and Rorschach Merger Sub, LLC . In connection with the Closing, Mr. Albert Dyrness received 882 shares of common stock, par value $0.01 per share, of the Company, in exchange of certain securities of Sonnet Mr. Dyrness held prior to the Closing. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.